Efficacy and safety of IDegLira vs. basal–bolus in patients with type 2 diabetes: DUAL VII trial

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com

ImprintTerms of ServicePrivacy PolicyAccessibility